Glucocorticoid effects on mesotelencephalic dopamine neurotransmission

Neuropsychopharmacology

Volumn 21, Issue 3, 1999, Pages 399-407

  Lindley, Steven E ^a   Bengoechea, Tasha G ^a   Schatzberg, Alan F ^a   Wong, Dona L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Corticosterone; Dopamine; Medial prefrontal cortex; Nucleus accumbens; Stress; Striatum; Tyrosine hydroxylase

Indexed keywords

3 HYDROXYBENZYLHYDRAZINE; CORTICOSTERONE; DIHYDROXYPHENYLACETIC ACID; DOPAMINE; GAMMA BUTYROLACTONE; GLUCOCORTICOID; HOMOVANILLIC ACID; METIROSINE; TYROSINE 3 MONOOXYGENASE;

ADRENALECTOMY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DNA SYNTHESIS; DOPAMINE METABOLISM; DOPAMINERGIC SYSTEM; MALE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; STRESS; SUBCUTANEOUS DRUG ADMINISTRATION; TELENCEPHALON;

3,4-DIHYDROXYPHENYLACETIC ACID; ADJUVANTS, ANESTHESIA; ADRENALECTOMY; ANIMALS; ANTI-INFLAMMATORY AGENTS; CORPUS STRIATUM; CORTICOSTERONE; DOPAMINE; MALE; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RESTRAINT, PHYSICAL; SODIUM OXYBATE; TELENCEPHALON; TYROSINE 3-MONOOXYGENASE;

EID: 0032809048     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0893-133X(98)00103-1     Document Type: Article

References (53)

1. Baetge E.E., Kaplan B.B., Reis D.J., Joh T.H. Translation of tyrosine hydroxylase from poly(A)-mRNA in pheochromocytoma cells is enhanced by dexamethasone. Proc Nat Acad Sci USA. 78:1981;1269-1273.
2. Brannan T., Prikhojan A., Martinez-Tica J., Yahr M.D. In vivo comparison of the effects of inhibition of MAO-A versus MAO-B on striatal L-DOPA and dopamine metabolism. J Neural Transm Park Dis Dement Sect. 10:1995;79-89.
3. Cador M., Dulluc J., Mormede P. Modulation of the locomotor response to amphetamine by corticosterone. Neuroscience. 56:1993;981-988.
4. Caesar P.M., Collins G.G., Sandler M. Catecholamine metabolism and monoamine oxidase activity in adrenalectomized rats. Biochem Pharmacol. 19:1970;921-926.
5. Claustre Y., Rivy J.P., Dennis T., Scatton B. Pharmacological studies on stress-induced increase in frontal cortical dopamine metabolism in the rat. J Pharmacol Experim Therapeut. 238:1986;693-700.
6. Cools A.R., Peeters B.W. Differences in spike-wave discharges in two rat selection lines characterized by opposite dopaminergic activities. Neurosci Lett. 134:1992;253-256.
7. Cooper J.R., Bloom F.E., Roth R.H. The Biochemical Basis of Neuropharmacology. 6th ed:1991;Oxford University Press, Oxford, UK.
8. Deutch A.Y., Cameron D.S. Pharmacological characterization of dopamine systems in the nucleus accumbens core and shell. Neuroscience. 46:1992;49-56.
9. Deutch A.Y., Clark W.A., Roth R.H. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res. 521:1990;311-315.
10. Dinan T.G. Noradrenergic and serotonergic abnormalities in depression. Stress-induced dysfunction? J Clin Psychiat. 57:1996;14-18.
11. Dunn A.J. Stress-related changes in cerebral catecholamine and indoleamine metabolism. Lack of effect of adrenalectomy and corticosterone J Neurochem. 51:1988;406-412.
12. Faunt J.E., Crocker A.D. Adrenocortical hormone status affects responses to dopamine receptor agonists. Eur J Pharmacol. 152:1988;255-261.
13. 2 receptors. Eur J Pharmacol. 162:1989;237-244.
14. Galloway M.P., Wolf M.E., Roth R.H. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors. Studies in vivo J Pharmacol Exper Therapeu. 236:1986;689-698.
15. Harfstrand A., Fuxe K., Cintra A., Agnati L.F., Zini I., Wikstrom A.C., Okret S., Yu Z.Y., Goldstein M., Steinbusch H., Verhofstad A., Gustafsson Glucocorticoid receptor immunoreactivity in monoaminergic neurons of rat brain. Proc Nat Acad Sci USA. 83:1986;9779-9783.
16. Imperato A., Puglisi-Allegra S., Casolini P., Angelucci L. Changes in brain dopamine and acetylcholine release during and following stress are independent of the pituitary-adrenocortical axis. Brain Res. 538:1991;111-117.
17. Imperato A., Puglisi-Allegra S., Grazia Scrocco M., Casolini P., Bacchi S., Angelucci L. Cortical and limbic dopamine and acetylcholine release as neurochemical correlates of emotional arousal in both aversive and nonaversive environmental changes. Neurochem Int. 20:1992;265S-270S.
18. Inoue T., Koyama T. Effects of acute and chronic administration of high-dose corticosterone and dexamethasone on regional brain dopamine and serotonin metabolism in rats. Prog Neuro-Psychopharmacol Biolog Psychiat. 20:1996;147-156.
19. Kvetnansky Rm., Fukuhara K., Pacak K., Cizza G., Goldstein D.S., Kopin I.J. Endogenous glucocorticoids restrain catecholamine synthesis and release at rest and during immobilization stress in rats. Endocrinology. 133:1993;1411-1419.
20. Kvetnansky R., Pacak K., Fukuhara K., Viskupic E., Hiremagalur B., Nankova B., Goldstein D.S., Sabban E.L., Kopin I.J. Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary-adrenocortical system. Ann NY Acad Sci. 771:1995;131-158.
21. Lewis E.J., Tank A.W., Weiner N., Chikaraishi D.M. Regulation of tyrosine hydroxylase mRNA by glucocorticoid and cyclic AMP in a rat pheochromocytoma cell line. Isolation of a cDNA clone for tyrosine hydroxylase mRNA. J Biolog Chem. 258:1983;14632-14637.
22. Lindley S.E., Gunnet J.W., Lookingland K.J., Moore K.E. Effects of alterations in the activity of tuberohypophysial dopaminergic neurons on the secretion of alpha-melanocyte stimulating hormone. Proc Soc Exper Biol Med. 188:1988;282-286.
23. Marinelli M., Piazza P.V., Deroche V., Maccari S., Le Moal M., Simon H. Corticosterone circadian secretion differentially facilitates dopamine-mediated psychomotor effect of cocaine and morphine. J Neurosci. 14:1994;2724-2731.
24. Markey K.A., Sze P.Y. Influence of ACTH on tyrosine hydroxylase activity in the locus coeruleus of mouse brain. Neuroendocrinology. 38:1984;269-275.
25. Meyer J.S. Biochemical effects of corticosteroids on neural tissues. Physiolog Rev. 65:1985;946-1020.
26. Nemeroff C.B. The psychoneuroendocrinology of depression. Hypothalamic-pituitary adrenal axis dysregulation Strecker Monograph Series. 30:1993;1-36.
27. Nestler E.J., Terwilliger R.Z., Halm E. Corticosterone increases protein tyrosine kinase activity in the locus coeruleus and other monoaminergic nuclei of rat brain. Molec Pharmacol. 35:1989;265-270.
28. Ortiz J., DeCaprio J.L., Kosten T.A., Nestler E.J. Strain-selective effects of corticosterone on locomotor sensitization to cocaine and on levels of tyrosine hydroxylase and glucocorticoid receptor in the ventral tegmental area. Neuroscience. 67:1995;383-397.
29. Overton P.G., Tong Z.Y., Brain P.F., Clark D. Preferential occupation of mineralocorticoid receptors by corticosterone enhances glutamate-induced burst firing in rat midbrain dopaminergic neurons. Brain Res. 737:1996;146-154.
30. Palkovits M. Isolated removal of hypothalamic or other brain nuclei of the rat. Brain Res. 59:1973;449-450.
31. Patacchioli F.R., Pontieri F.E., Di Grezia R., Colangelo V., Angelucci L., Orzi F. Increased functional response to cocaine challenge following recovery from chronic corticosterone in the rat. Eur J Pharmacol. 336:1997;159-162.
32. Paxinos G., Watson C. The Rat brain in Sterotaxic Coordinates. 3rd ed:1997;Academic Press, San Diego, CA.
33. Piazza P.V., Barrot M., Rouge-Pont F., Marinelli M., Maccari S., Abrous D.N., Simon H., Le Moal M. Suppression of glucocorticoid secretion and antipsychotic drugs have similar effects on the mesolimbic dopaminergic transmission. Proc Nat Acad Sci USA. 93:1996;15445-15450. a.
34. Piazza P.V., Deroche V., Deminiere J.M., Maccari S., Le Moal M., Simon H. Corticosterone in the range of stress-induced levels possesses reinforcing properties. Implications for sensation-seeking behaviors Proc Nat Acad Sci USA. 90:1993;11738-11742.
35. Piazza P.V., Le Moal M. Pathophysiological basis of vulnerability to drug abuse. Role of an interaction between stress, glucocorticoids, and dopaminergic neurons Ann Rev Pharamacol Toxicol. 36:1996;359-378.
36. Piazza P.V., Rouge-Pont F., Deroche V., Maccari S., Simon H., Le Moal M. Glucocorticoids have state-dependent stimulant effects on the mesencephalic dopaminergic transmission. Proc Nat Acad Sci USA. 93:1996;8716-8720. b.
37. Rivet J.M., Stinus L., LeMoal M., Mormede P. Behavioral sensitization to amphetamine is dependent on corticosteroid receptor activation. Brain Res. 498:1989;149-153.
38. Rodriguez-Gomez J.A., Venero J.L., Vizuete M.L., Cano J., Machado A. Deprenyl induces the tyrosine hydroxylase enzyme in the rat dopaminergic nigrostriatal system. Brain Research. Molecular Brian Research. 46:1997;31-38.
39. Roth R.H., Murrin L.C., Walters J.R. Central dopaminergic neurons. Effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid Eur J Pharmacol. 36:1976;163-171.
40. Roth R.H., Tam S.Y., Ida Y., Yang J.X., Deutch A.Y. Stress and the mesocorticolimbic dopamine systems. Ann NY Acad Sci. 537:1988;138-147.
41. Rothschild A.J., Langlais P.J., Schatzberg A.F., Miller M.M., Saloman M.S., Lerbinger J.E., Cole J.O., Bird E.D. The effects of a single acute dose of dexamethasone on monoamine and metabolite levels in rat brain. Life Sci. 36:1985;2491-2501.
42. Rouge-Pont F., Marinelli M., Le Moal M., Simon H., Piazza P.V. Stress-induced sensitization and glucocorticoids. II. Sensitization of the increase in extracellular dopa- mine induced by cocaine depends on stress-induced corticosterone secretion. J Neurosci. 15:1995;7189-7195.
43. Schatzberg A.F., Rothschild A.J. The roles of glucocorticoid and dopaminergic systems in delusional (psychotic) depression. Ann NY Acad Sci. 537:1988;462-471.
44. Schatzberg A.F., Rothschild A.J., Langlais P.J., Bird E.D., Cole J.O. A corticosteroid/dopamine hypothesis for psychotic depression and related states. J Psychiat Res. 19:1985;57-64.
45. Smith M.A., Brady L.S., Glowa J., Gold P.W., Herkenham M. Effects of stress and adrenalectomy on tyrosine hydroxylase mRNA levels in the locus ceruleus by in situ hybridization. Brain Res. 544:1991;26-32.
46. Stachowiak M.K., Rigual R.J., Lee P.H., Viveros O.H., Hong J.S. Regulation of tyrosine hydroxylase and phenylethanolamine N-methyltransferase mRNA levels in the sympathoadrenal system by the pituitary-adrenocortical axis. Brain Res. 427:1988;275-286.
47. Tanganelli S., Fuxe K., von Euler G., Eneroth P., Agnati L.F., Ungerstedt U. Changes in pituitary-adrenal activity affect the apomorphine and cholecystokinin-8-induced changes in striatal dopamine release using microdialysis. J Neural Transm. Gen Sect. 81:1990;183-194.
48. Thomas D.N., Post R.M., Pert A. Central and systemic corticosterone differentially affect dopamine and norepinephrine in the frontal cortex of the awake freely moving rat. Ann NY Acad Sci. 746:1994;467-469.
49. Van Loon G.R., Sole M.J., Kamble A., Kim C., Green S. Differential responsiveness of central noradrenergic and dopaminergic neuron tyrosine hydroxylase to hypophysectomy, ACTH, and glucocorticoid administration. Ann NY Acad Sci. 297:1977;284-294.
50. Veals J.W., Korduba C.A., Symchowicz S. Effect of dexamethasone on monoamine oxidase inhibiton by iproniazid in rat brain. Eur J Pharmacol. 41:1977;291-299.
51. Watanabe Y., Weiland N.G., McEwen B.S. Effects of adrenal steroid manipulations and repeated restraint stress on dynorphin mRNA levels and excitatory amino acid receptor binding in hippocampus. Brain Res. 680:1995;217-225.
52. Wolkowitz O., Sutton M., Koulu M., Labarca R., Wilkinson L., Doran A., Hauger R., Pickar D., Crawley J. Chronic corticosterone administration in rats. Behavioral and biochemical evidence of increased central dopaminergic activity Eur J Pharmacol. 122:1986;329-338.
53. Wolkowitz O.M. Prospective controlled studies of the behavioral and biological effects of exogenous corticosteroids. Psychoneuroendocrinology. 19:1994;233-255.